We aimed to investigate the role of hepatocyte SIRT6 in the development of atherosclerosis and further characterize the mechanism underlying SIRT6’s effect on NAFLD. This evidence concerns the gene SIRT6 and metabolic dysfunction-associated steatotic liver disease.